Mission possible

Andrew L. Hopkins, Michael J. Witty and Solomon Nwaka
Additional contact information
Andrew L. Hopkins: Andrew L. Hopkins is head of chemical genomics at Pfizer Global Research and Development, Sandwich, UK.
Michael J. Witty: Michael J. Witty is group director of global portfolio management at Pfizer Animal Health, Sandwich, UK.
Solomon Nwaka: Solomon Nwaka is leader of drug-discovery activities at the Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland.

Nature, 2007, vol. 449, issue 7159, 166-169

Abstract: One billion people worldwide suffer from tropical diseases. Andrew L. Hopkins, Michael J. Witty and Solomon Nwaka explain how drug-discovery networks might be scaled up to address the lack of treatments cost-effectively.

Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/449166a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:449:y:2007:i:7159:d:10.1038_449166a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/449166a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().